Information Journal Paper
APA:
Copy. (2020). Anti-interleukin-17A and anti-interleukin-23 antibodies may be effective against Alzheimer's disease: Role of neutrophils in the pathogenesis. BRAIN AND BEHAVIOR, 10(1), 0-0. SID. https://sid.ir/paper/755685/en
Vancouver:
Copy. Anti-interleukin-17A and anti-interleukin-23 antibodies may be effective against Alzheimer's disease: Role of neutrophils in the pathogenesis. BRAIN AND BEHAVIOR[Internet]. 2020;10(1):0-0. Available from: https://sid.ir/paper/755685/en
IEEE:
Copy, “Anti-interleukin-17A and anti-interleukin-23 antibodies may be effective against Alzheimer's disease: Role of neutrophils in the pathogenesis,” BRAIN AND BEHAVIOR, vol. 10, no. 1, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/755685/en